Selected publications

2020

1. Strazic Geljic I, Kucan Brlic P, Angulo G, Brizic I, Lisnic B, Jenus T, Juranic Lisnic V, Pietri GP, Engel P, Kaynan N, Zeleznjak J, Schu P, Mandelboim, O, Krmpotic A, Angulo A, Jonjic S, Lenac Rovis T: Cytomegalovirus protein m154 perturbs the adaptor protein-1 compartment mediating broad-spectrum immune evasion. eLife, 9:e50803.doi: 10.7554/eLife.50803. 2020

2019

1. Kučan Brlić P, Lenac Roviš T, Cinamon G, Tsukerman P, Mandelboim O, Jonjić S: Targeting PVR (CD155) and its receptors in anti-tumor therapy. Cellular and Molecular Immunology, doi: 10.1038/s41423-018-0168-y. 16(1):40-52. 2019 (IF: 8.213)

2. Yunis J, Farrell HE, Bruce K, Lawler C, Wyer O, Davis-Poynter N, Brizić I, Jonjić S, Adler B, Stevenson P: Murine Cytomegalovirus glycoprotein O promotes epithelial cell infection in vivo. Journal of Virology, doi: 10.1128/JVI.01378-18. 93(3). 2019 (IF: 4.324)

3. Stojanovic B, Milovanovic J, Arsenijevic A, Strazic Geljic I, Arsenijevic N, Jonjic S, Lukic M, Milovanovic M: Galectin-3 deficiency facilitates TNF-α-dependent hepatocyte death and liver inflammation in MCMV infection. Frontiers in Microbiology, doi: 10.3389/fmicb.2019.00185. 10:185. 2019 (IF: 2.459)

4. Brizić I, Hiršl L, Šustić M, Golemac M, Britt W, Krmpotić A, Jonjić S: CD4 T cells are required for maintenance of CD8 TRM cells and virus control in the brain of MCMV‑infected newborn mice. Medical Microbiology and Immunology, doi:10.1007/s00430-019-00601-0. 208(3-4):487-494. 2019 (2.960)

5. Krmpotić A, Podlech J, Reddehase M, Britt W, Jonjić S: Role of antibodies in confining cytomegalovirus after reactivation from latency: three decades’ résumé. Medical Microbiology and Immunology, doi:10.1007/s00430-019-00600-1. 208(3-4):415-429. 2019 (IF: 2.960)

6. Pallmer K, Barnstorf I, Baumann N, Borsa M, Jonjic S, Oxenius A: NK cells negatively regulate CD8 T cells via Natural Cytotoxicity Receptor (NCR) 1 during LCMV infection. PLoS Pathogens, doi:10.1371/journal.ppat.1007725. 15(4):e1007725. 2019 (6.463)

7. Železnjak K, Juranić Lisnić V, Popović B, Lisnić B, Babić M, Halenius A, L’Hernault A, Lenac Roviš T, Hengel H, Erhard F, Redwood A, Vidal S, Doelken l, Krmpotić A, Jonjić S: The complex of MCMV proteins and MHC class I evades NK cell control and drives the evolution of virus-specific activating Ly49 receptors. Journal of experimental medicine, doi: 10.1084/jem.20182213. 216(8):1809-1827. 2019 (IF: 10.892)

8. Berry R, Watson G, Jonjic S, Delgi-Esposti M, Rossjohn J: Modulation of Innate and Adaptive Immunity by Cytomegaloviruses. Nature Reviews of Immunology, doi:10.1038/s41577-019-0225-5. 2019 (IF: 44.019)

9. Kalfopoulou E, Laverde D, Miklic K, Saavedra F, Malic S, Carboni F, Adamo R, Lenac Rovis T, Jonjic S, Huebner J: Development of opsonic mouse monoclonal antibodies against multidrug resistant enterococci. Infection and Immunity, doi: 10.1128/IAI.00276-19. 87(9). 2019 (IF: 3.160)

10. Won Sung C, Seleme M, Payne S, Jonjic S, Hirose K, Britt W: Virus-induced cochlear inflammation in newborn mice alters auditory function. The Journal of Clinical Investigation - Insight, doi:10.1172/jci.insight.128878. 4(17):e128878. 2019 (IF: 6.014)

11. Aguilar OA, Sampaio IS, Rahim MMA, Samaniego JD, Tilahun ME, Krishnamoorthy M, Popović B, Babić M, Krmpotić A, Treanor B, Margulies DH, Allan DSJ, Makrigiannis AP, Jonjić S, Carlyle JR: Mouse cytomegalovirus m153 protein stabilizes expression of the inhibitory NKR-P1B ligand, Clr-b. Journal of Virology, doi: 10.1128/JVI.01220-19. 2019 (IF: 4.324)

12. Cossarizza A, Chang HD, Radbruch A...Jonjic S...Zimmermann J, Zychlinsky A (>200): Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). European Journal of Immunology, doi: 10.1002/eji.201970107. 49(10):1457-1973. 2019 (IF: 4.695)

13. Arapović J, Rajič B, Pati S, Brizić I, Azinović I, Šušak B, Ostojić M, Tutiš B, Raguž AB, Tomić V, Jonjić S, Boppana S: Cytomegalovirus Seroprevalence and Birth Prevalence of Congenital CMV Infection in Bosnia and Herzegovina: A Single-Center Experience. The Pediatric Infectious Disease Journal, doi: 10.1097/INF.0000000000002510. 2019 (IF: 2.723)

2018

1. Milbradt J, Sonntag E, Wagner S, Strojan H, Wangen C, Lenac Rovis T, Lisnic B, Jonjic S, Sticht H, Britt WJ, Schlötzer-Schrehardt U, Marschall M. Human Cytomegalovirus Nuclear Capsids Associate with the Core Nuclear Egress Complex and the Viral Protein Kinase pUL97. Viruses. doi: 10.3390/v10010035. 2018 Jan 13;10(1). pii: E35.2.

2. Glasner A, Levi A, Enk J, Isaacson B, Viukov S, Orlanski S, Scope A, Neuman T, Enk CD, Hanna JH, Sexl V, Jonjic S, Seliger B, Zitvogel L, Mandelboim O. NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis. Immunity. 2018 Jan 16;48(1):107-119.e4. doi: 10.1016/j.immuni.2017.12.007.

3. Brizić I, Sušak B, Arapović M, Huszthy PC, Hiršl L, Kveštak D, Lisnić VJ, Golemac M, Pugel EP, Tomac J, Oxenius A, Britt WJ, Arapović J, Krmpotić A, Jonjić S: Brain-resident memory CD8+ T cells induced by congenital CMV infection prevent brain pathology and virus reactivation. European Journal of Immunology, doi: 10.1002/eji.201847526. 48(6):950-964. 2018 (IF: 4.695)

4. Hiršl L, Brizić I, Jenuš T, Juranić Lisnić V, Reichel JJ, Jurković S, Krmpotić A, Jonjić S: Murine CMV expressing the high affinity NKG2D ligand MULT-1: a Model for the development of cytomegalovirus-Based Vaccines. Frontiers in Immunology, doi: 10.3389/fimmu.2018.00991. 9:991. 2018 (IF: 5.511)

5. Šestan M, Marinović S, Kavazović I, Cekinović Đ, Wueest S, Turk Wensveen T, Brizić I, Jonjić S, Konrad D, Wensveen FM, Polić B: Virus-Induced Interferon-γ Causes Insulin Resistance in Skeletal Muscle and Derails Glycemic Control in Obesity. Immunity, doi: 10.1016/j.immuni.2018.05.005. 49(1):164-177.e6. 2018 (IF: 21.522)

6. Brizić I, Lisnić B, Brune W, Hengel H, Jonjić, S: Cytomegalovirus infection: Mouse model. Current Protocols in Immunology, e51. doi: 10.1002/cpim.51. 2018

7. Zaytseva OO, Jansen BC, Hanić M, Mrčela M, Razdorov G, Stojković R, Erhardt J, Brizić I, Jonjić S, Pezer M, Lauc G: MIgGGly (mouse IgG glycosylation analysis) - a high-throughput method for studying Fc-linked IgG N-glycosylation in mice with nanoUPLC-ESI-MS. Scientific Reports, doi:10.1038/s41598-018-31844-1. 8:13688. 2018 (IF: 4.011)

8. Lučin P, Kareluša Lj, Blagojević Zagorac G, Mahmutefendić Lučin H, Pavišić V, Jug Vučko N, Lukanović Jurić S, Marcelić M, Lisnić B, Jonjić S: Cytomegaloviruses Exploit Recycling Rab Proteins in the Sequential Establishment of the Assembly Compartment. Frontiers in Cell and Developmental Biology, doi:10.3389/fcell.2018.00165. 6:165. 2018 (IF: 5.206)

9. Berhani O, Glasner A, Kahlon S, Duev‐Cohen A, Yamin R, Horwitz E, Enk J, Moshel O, Varvak A, Porgador A, Jonjic S, Mandelboim O: Human anti-NKp46 antibody for studies of NKp46-dependent NK cell function and its applications for type 1 diabetes and cancer research. European Journal of Immunology, doi:10.1002/eji.201847611. 49(2):228-241. 2018 (IF: 4.695)

2017

1. Brizić I, Hiršl L, Britt WJ, Krmpotić A, Jonjić S. Immune responses to congenital cytomegalovirus infection. Microbes and Infection. doi: 10.1016/j.micinf.2017.12.010. 2017 Dec 26. pii: S1286-4579(17)30233-2.2. Molgora M, Bonavita E, Ponzetta A, Riva F, Barbagallo M, Jaillon S, Popović B, Bernardini G, Magrini E, Gianni F, Zelenay S, Jonjić S, Santoni A, Garlanda C, Mantovani A. IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity. Nature. doi: 10.1038/nature24293., 2017 Nov 2;551(7678):110-114.

2. Cossarizza A, Chang HD, Radbruch A...Jonjic S...Zimmermann J (>200): Guidelines for the use of flow cytometry and cell sorting in immunological studies. European Journal of Immunology, doi: 10.1002/eji.201646632., 47(10):1584-1797, 2017

3. Goodier MR, Jonjić S, Riley EM, Lisnić VJ: CMV and Natural Killer cells: shaping the response to vaccination. European Journal of Immunology, doi: 10.1002/eji.201646762., 2017

4. Molgora M, Bonavita E, Ponzetta A, Riva F, Barbagallo M, Jaillon S, Popovic B, Bernardini G, Magrini E, Gianni F, Zelenay S, Jonjic S, Santoni A, Garlanda C, Mantovani A: IL-1R8 is a checkpoint in NK cells regulating anti-tumor and anti-viral activity. Nature, doi:10.1038/nature24293, 2017

5. Cohrs RJ, Lee KS, Beach A, Sanford B, Baird NL, Como C, Graybill C, Jones D, Tekeste E, Ballard M, Chen X, Yalacki D, Frietze S, Jones K, Lenac Rovis T, Jonjić S, Haas J, Gilden D: Targeted Genome Sequencing Reveals Varicella-Zoster Virus Open Reading Frame 12 Deletion. Journal of Virology, doi: 10.1128/JVI.01141-17, 2017

6. Nabekura T, Gotthardt D, Niizuma K, Trsan T, Jenus T, Jonjic S, Lanier LL: Cutting Edge: NKG2D Signaling Enhances NK Cell Responses but Alone Is Insufficient To Drive Expansion during Mouse Cytomegalovirus Infection. Journal of Immunology, doi: 10.4049/jimmunol.1700799;199(5):1567-1571, 2017

7. Zeeshan Chaudhry M, Kasmapour B, Plaza-Sirvent C, Bajagic M, Casalegno Garduño R, Borkner L, Lenac Rovis T, Scrima A, Jonjic S, Schmitz I, Cicin-Sain: UL36 Rescues Apoptosis Inhibition and In vivo Replication of a Chimeric MCMV Lacking the M36 Gene. Frontiers in Cellular and Infection Microbiology, doi.org/10.3389/fcimb.2017.00312, 7:312, 20179. Miletic A, Lenartic M, Popovic B, Brizic I, Trsan T, Miklic K, Mandelboim O, Krmpotic A, Jonjic S: NCR1-deficiency diminishes the generation of protective murine cytomegalovirus antibodies by limiting follicular helper T-cell maturation. European Journal of Immunology. doi: 10.1002/eji.201646763., 2017, Epub ahead of print

8. Tršan T, Vuković K, Filipović P, Brizić AL, Lemmermann NAW, Schober K, Busch DH, Britt WJ, Messerle M, Krmpotić A, Jonjić S: Cytomegalovirus vector expressing RAE-1γ induces enhanced anti-tumor capacity of murine CD8+ T cells. European Journal of Immunology. doi: 10.1002/eji.201746964., 2017, Epub ahead of print

9. Hirche C, Frenz T, Haas SF, Döring M, Borst K, Tegtmeyer PK, Brizic I, Jordan S, Keyser K, Chhatbar C, Pronk E, Lin S, Messerle M, Jonjic S, Falk CS, Trumpp A, Essers MAG, Kalinke U: Systemic Virus Infections Differentially Modulate Cell Cycle State and Functionality of Long-Term Hematopoietic Stem Cells In Vivo. Cell Reports, 19, 2345-2356, 2017

10. Chan B, Magalhães VG, Lemmermann NAW, Juranić Lisnić V, Stempel M, Bussey KA, Reimer E, Podlech J, Lienenklaus S, Reddehase MJ, Jonjić S, Brinkmann MM: The murine cytomegalovirus M35 protein antagonizes type I IFN induction downstream of pattern recognition receptors by targeting NF-κB mediated transcription. PLOS Pathogens, 13(5): e1006382, 2017

11. Zeleznjak J, Popovic B, Krmpotic A, Jonjic S, Lisnic VJ: Mouse cytomegalovirus encoded immunoevasins and evolution of Ly49 receptors - sidekicks or enemies? Immunology Letters, pii: S0165-2478(17)30123-2. doi: 10.1016/j.imlet.2017.04.007., 2017 Epub ahead of print

12. Popovic B, Golemac M, Podlech J, Zeleznjak J, Bilic-Zulle L, Lukic M, Cicin-Sain L, Reddehase M, Sparwasser T, Krmpotic A, Jonjic S: IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection, PLOS Pathogens, 13(4):e1006345, 2017

13. González-Motos V, Ritter B, Jürgens C, Kropp KA, Duran E, Larsen O, Ouwendijk WJD, Lenac Rovis T, Jonjic S, Verjans GMG, Sodeik B, Krey T, Bauerfeind R, Schulz TF, Kaufer BB, Kalinke U, Proudfoot AEI, Rosenkilde MM, Viejo-Borbolla A: Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration. PLOS Pathogens, 13(5):e1006346, 2017

14. Aguilar O, Berry R, Rahim, M, Reichel J, Popovic B, Tanaka M, Fu Z, Balaji G, Lau T, Tu M, Kirkham C, Mahmoud A, Mesci A, Krmpotic A, Allan D, Makrigiannis A, Jonjic S, Rossjohn J, Carlyle J: A Viral Immunoevasin Controls Innate Immunity by Targeting the Prototypical Natural Killer Cell Receptor Family. Cell, 169, 58–71, 2017

15. Diab M, Glasner A, Issacson B, Bar-On Y, Drori Y, Yamin R, Duev-Cohen A, Danziger O, Zamostiano R, Mandelboim M, Jonjic S, Bacharach E, Mandelboim O: NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection. European Journal of Immunnology, doi: 10.1002/eji.201646756, 2017

16. Milovanović J, Popović B, Milovanović M, Kveštak D, Arsenijević A, Stojanović B, Tanasković I, Krmpotić A, Arsenijević N, Jonjić S, Lukić M: Murine Cytomegalovirus Infection Induces Susceptibility to EAE in Resistant, BALB/C mice. Frontiers in Immunology, 8:192, doi: 10.3389/fimmu.2017.00192, 2017

17. Seleme M, Kosmac K, Jonjic S, Britt W: TNFα Induced Recruitment of Inflammatory Mononuclear Cells Leads to Inflammation and Altered Brain Development in MCMV Infected Newborn Mice. Journal of Virology, 91(8), pii: JVI.01983-16, doi: 10.1128/JVI.01983-16, 2017

2016

1. Tomic A,Varanas PR, Golemac M, Malic S, Riese P, Borst EM, Mischak-Weissinger E, Guzmán CA, Krmpotić A, Jonjic S, Messerle M:Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand, PLOS Pathogens, 12(12):e1006015, 2016

2. Thiel N, Keyser KA, Lemmermann N, Oduro JD, Wagner K, Elsner C, Halenius A, Lenac Rovis T, Brinkmann M, Jonjic S, Cicin-Sain L, Messerle M: The Mouse Cytomegalovirus Gene m42 Targets Surface Expression of the Protein Tyrosine Phosphatase CD45 in Infected Macrophages, PLOS Pathogens, 12(12):e1006057, 2016

3. Lenac Rovis T, Kucan Brlic P, Kaynan N, Juranic Lisnic V, Brizic I, Jordan S, Tomic A, Kvestak D, Babic M, Tsukerman P, Colonna M, Koszinowski U, Messerle M, Mandelboim O, Krmpotic A, Jonjic S: Inflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infection, Journal of Experimental Medicine, 213(9):1835-50, 2016

4. Vitenshtein A, Weisblum Y, Hauka S, Halenius A, Oiknine-Djian E,Tsukerman P, Bauman Y, Bar-On Y, Stern-Ginossar N, Enk J, Ortenberg R, Tai J, Markel G, Blumberg RS, Hengel H, Jonjic S, Wolf DG, Adler H, Kammerer R, Mandelboim O: CEACAM1-Mediated Inhibition of Virus Production, Cell Reports,15(11): 2331–2339, 2016

5. Sonntag E, Hamilton ST, Bahsi H, Wagner S, Jonjić S, Rawlinson WD, Marschall M, Milbradt J: Cytomegalovirus pUL50 is the multi-interacting determinant of the core nuclear egress complex (NEC) that recruits cellular accessory NEC components. Journal of General Virology, 97(7):1676-85, 2016

6. Borst EM, Bauerfeind R, Binz A, Stephan T, Neuber S, Wagner K, Steinbrück L, Sodeik B, Lenac Rovis T, Jonjic S, Messerle M: The Essential Human Cytomegalovirus Proteins pUL77 and pUL93 are Structural Components Necessary for Viral Genome Encapsidation. Journal of Virology, 90(13):5860-75, 2016

7. Arapović M, Brizić I, Popović B, Jurković S, Jordan S, Krmpotić A, Arapović J, Jonjić S: Intrinsic contribution of perforin to NK cell homeostasis during viral infection. Frontiers in Immunology, 7:133, doi: 10.3389/fimmu.2016.00133, 2016

8. Houston A, Williams J, Lenac Rovis T, Shanley D, O'Riordan R, Kiely P, Ball M, Barry O, Kelly J, Fanning A, MacSharry J, Mandelboim O, Singer B, Jonjic S, Moore T: Pregnancy-specific glycoprotein (PSG) expression in normal gastrointestinal tract and in tumours detected with novel monoclonal antibodies. mAbs, 8(3):491-500, 2016

2015

1. Glasner A, Simic H, Miklić K,Roth Z, Berhani O, Khalaila I, Jonjic S, Mandelboim O: Expression, Function, and Molecular Properties of the Killer Receptor Ncr1-Noé; Journal of Immunology, 195(8):3959-3969, 2015

2. Glasner A, Roth Z, Varvak A, Miletic A, Isaacson B, Bar-On Y, Jonjic S, Khalaila I, Mandelboim O: Identification of putative novel O-glycosylations in the NK killer receptor Ncr1 essential for its activity. Cell Discovery, 1:15036, 2015

3. Lisnic B, Juranic Lisnic V, Jonjic S: NK cell interplay with cytomegaloviruses, Current Opinion in Virology, 15:9–18, 2015

4. Verweij M, Wellish M, Whitmer T, Malouli D, Lapel M, Jonjić S, Haas J, DeFilippis V, Mahalingam R, Früh K: Varicella Viruses Inhibit Interferon- Stimulated JAK-STAT Signaling through Multiple Mechanisms, PLoS Pathogens, 11(5): e1004901. doi:10.1371/journal.ppat., 2015

5. Yossef R, Gur C, Shemesh A, Guttman O, Hadad U, Nedvetzki S, Miletic A, Nalbandyan K, Cerwenka A, Jonjic S, Mandelboim O, Porgador A: Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes. PlosOne, 10(2):e0118936, 2015

6. Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, Shussman N, Almogy G, Cuapio A, Hofer E, Mevorach D, Tabib A, Ortenberg R, Markel G, Miklic K, Jonjic S, Brennan CA, Garrett WS, Bachrach G, Mandelboim O: Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack. Immunity, 42(2):344-55, 2015

7. Lemmermann N, Krmpotic A, Podlech J, Brizic I, Prager A, Adler H, Karbach A, Wu Y, Jonjic S, Reddehase MJ, Adler B: Non-redundant and redundant roles of cytomegalovirus gH/gL complexes in host organ entry and intra-tissue spread. PLoS Pathogens, DOI:10.1371/journal.ppat.1004640, 2015

2014

1. Eifler M, Uecker R, Weisbach H, Bogdanow B, Richter E, König L, Vetter B, Lenac-Rovis T, Jonjic S, Neitzel H, Hagemeier C, Wiebusch L: PUL21a-Cyclin A2 Interaction is Required to Protect Human Cytomegalovirus-Infected Cells from the Deleterious Consequences of Mitotic Entry. PLoS Pathogens, 13;10(10):e1004514. doi: 10.1371/journal.ppat.1004514; 2014

2. Gabaev I, Elbasani E, Ameres S, Steinbrück L, Stanton R, Döring M, Lenac Rovis T, Kalinke U, Jonjic S, Moosmann A, Messerle M: "Expression of the Human Cytomegalovirus UL11 Glycoprotein in Viral Infection and Evaluation of its Effect on Virus-Specific CD8 T Cells", Journal of Virology, pii: JVI.01691-14, 88(24):14326, 2014

3. Brizic I, Lenac Rovis T, Krmpotic A, Jonjic S: ''MCMV avoidance of recognition and control by NK cells.'', Seminars in Immunopathology, 36(6):641-50, 2014

4. Baird NL, Bowlin JL, Yu X, Jonjic S, Haas J, Cohrs RJ, Gilden D: Varicella zoster virus DNA does not accumulate in infected human neurons.Virology, 458-459:1-3, 2014

5. Crouse J, Bedenikovic G, Wiesel M, Ibberson M, Xenarios I, Von Laer D, Kalinke U, Vivier E, Jonjic S, Oxenius A: Type I Interferons Protect T Cells against NK Cell Attack Mediated by the Activating Receptor NCR1. Immunity, 19;40(6):961-73, 2014

6. Zarama A, Perez-Carmona N, Farre´ D, Tomic A, Borst EM, Messerle M, Jonjic S, Engel P, Angulo A: Cytomegalovirus m154 hinders CD48 cell-surface expression and promotes viral escape from host natural killer cell control. PLoS Pathogens, 10(3):e1004000 doi:10.1371/journal.ppat.1004000; 2014

7. Trilling M, Khanh Le V, Rashidi-Alavijeh J, Katschinski B, Scheller J, Rose-John S, Androsiac G, Jonjic S, Poli V, Pfeffer K, Hengel H: 'Activated' S TAT proteins - a paradoxical consequence of inhibited JAK-STAT signalling in cytomegalovirus-infected cells. Journal of Immunology, 192(1):447-58; 2014

2013

1. Trsan T, Busche A, Abram M, Wensveen FM, Lemmermann NA, Arapovic M, Babic M,Tomic A, Golemac M, Brinkmann MM, Jäger W, Oxenius A, Polic B, Krmpotic A, Messerle M, Jonjic S: Superior induction and maintenance of protective CD8 T cells in mice infected with MCMV vector expressing RAE-1γ. Proceedings of the National Academy of Sciences of the United States of America, 110(41):16550-5; 2013 (IF: 9.737, Q1 in Multidisciplinary sciences)

2. Juranic Lisnic V, Babic Cac M, Lisnic B, Trsan T, Mefferd A, Mukhopadhyay CD, Cook CH, Jonjic S, Trgovcich J: Dual Analysis of the Murine Cytomegalovirus and Host Cell Transcriptomes Reveal New Aspects of the Virus-Host Cell Interface.PLoS Pathogens, 9(9):e1003611. doi: 10.1371/journal.ppat.1003611. 2013 (IF: 8.136, Q1 in Microbiology, Q1 in Parasitology and Q1 in Virology)

3. Stanietsky N, Lenac T, Glasner A, Seidel E, Tsukerman P, Yamin R, Enk J, Jonjic S, Mandelboim O: Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR. European Journal of Immunology, 43(8):2138-50; 2013 (IF: 4.970, Q1 in Immunology)

4. Lenac Rovis T, Bailer SM, Pothineni VR, Ouwendijk WJ, Simic H, Babic M, Miklic K, Malic S, Verweij MC, Baiker A, Gonzalez O, von Brunn A, Zimmer R, Früh K,Verjans GM, Jonjic S, Haas J.:A comprehensive analysis of varicella zoster virus proteins using a new monoclonal antibody collection. Journal of Virology, 87(12):6943-6954; 2013 (IF: 5.076, Q1 in Virology)

5. Miletic A, Krmpotic A, Jonjic S: The evolutionary arms race between NK cells and viruses: Who gets the short end of the stick? European Journal of Immunology, 43(4):867-77; 2013 (IF: 4.970, Q1 in Immunology)

6. Lankry D, Lenac Rovis T, Jonjic S, Mandelboim O:The interaction between CD300a and Phosphatidylserine inhibits tumor cell killing by NK cell. European Journal of Immunology, doi: 10.1002/eji.201343433; 2013 (IF: 4.970, Q1 in Immunology)

2012

1. Borst M, Kleine-Albers J, Gabaev I, Babic M, Wagner K, Binz A, Degenhardt I, Kalesse M, Jonjic S, Bauerfeind R, Messerle M: The human cytomegalovirus UL51 protein is essential for viral genome cleavage-packaging and interacts with the terminase subunits pUL56 and pUL89. Journal of Virology, 87(3):1720-32; 2012 (IF: 5.076, Q1 in Virology)

2. Yu X, Seitz S, Pointon T, Bowlin J, Cohrs R, Jonjic S, Haas J, Wellish M, Gilden D: Varicella Zoster Virus Infection of Highly Pure Terminally Differentiated Human Neurons. Journal of Neurovirology, 19(1):75-81; 2013 (IF: 2.850, Q3 in Neurosciences and Q2 in Virology)

3. Rodrıguez-Martin S, Kropp K, Wilhelmi V, Juranic Lisnic V,Yuan Hsieh W, Blanc M, Livingston A, Busche A, Tekotte H, Messerle M, Auer M, Fraser I, Jonjic S, Angulo A, Reddehase M,Ghazal P: Ablation of the Regulatory IE1 Protein of Murine Cytomegalovirus Alters In Vivo Pro-inflammatory TNFalpha Production during Acute Infection. PLoS Pathogens 8(8):e1002901; 2012 (IF: 8.136, citations: 1, Q1 in Microbiology, Q1 in Parasitology and Q1 in Virology)

4. Glasner A, Zurunic A, Meningher T, Lenac Rovis T, Tsukerman P, Bar-On Y, Yamin R, Meyers AF, Mandeboim M, Jonjic S, Mandelboim O. Elucidating the mechanisms of influenza virus recognition by Ncr1. PLoS One. 7(5), 2012.

5. Mandaric S, Walton SM, Rülicke T, Richter K, Girard-Madoux MJ, Clausen BE, Zurunic A, Kamanaka M, Flavell RA, Jonjic S, Oxenius A. IL-10 Suppression of NK/DC Crosstalk Leads to Poor Priming of MCMV-Specific CD4 T Cells and Prolonged MCMV Persistence. PLoS Pathog. 8(8), 2012.

2011

1. Jovanovic I, Radosavljevic G, Mitrovic M, Lisnic Juranic V, McKenzie A, Arsenijevic N, Jonjic S, Lukic M: ST2 Deletion Enhances Innate and Acquired Immunity to Murine Mammary Carcinoma. European Journal of Immunology, 41:7,1902-1912; 2011 (IF: 5.103, Q1 in Immunology)

2. Radosavljevic G, Jovanovic I, Majstorovic I, Mitrovic M, Lisnic VJ, Arsenijevic N, Jonjic S, Lukic ML: Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity. Clinical and Experimental Metastasis, 28(5):451-62; 2011 (IF: 3.524, Q2 in Oncology)

2010

1. Slavuljica I, Busche A, Babic M, Mitrovic M, Gašparovic I, Cekinovic D, Markova Car E, Pernjak Pugel E, Cikovic A, Juranic Lisnic V, Britt WJ, Koszinowski U, Messerle M, Krmpotic A, Jonjic S. Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. J Clin Invest. 120(12):4532-45, 2010.

2. Babic M, Pyzik M, Zafirova B, Mitrovic M, Butorac V, Lanier LL, Krmpotic A, Vidal SM and Jonjic S. Cytomegalovirus immunoevasin reveals the physiological role of „missing self“ recognition in NK cell dependent virus control in vivo. J Exp Med. 207(12):2663-2673, 2010.

3. Lankry D, Simic H, Klieger Y, Levi-Schaffer F, Jonjic S, Mandelboim O. Expression and function of CD300 in NK cells. J Immunol. 185(5):2877-86, 2010.

4. Juranic Lisnic V, Krmpotic A, Jonjic S: Modulation of natural killer cell activity by viruses. Curr Opin Microbiol. 13:1-10, 2010.

2009

52. Stanietsky N, Simic H, Arapovic J, Toporik A, Levy O, Novik A, Levine Z, Beiman M, Dassa L, Achdout H, Stern-Ginossar N, Tsukerman P, Jonjic S, Mandelboim O. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc Natl Acad Sci USA. 106(42):17858-63, 2009.

1. Arapovic J, Lenac T, Antulov R, Polic B, Ruzsics Z, Carayannopoulos LN, Koszinowski UH, Krmpotic A, Jonjic S.: Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus. J Virol. 83(16):8198-207, 2009.

2. Kielczewska A, Pyzik M, Sun T, Krmpotic A, Lodoen M B., Munks M W., Babic M, Hill A B., Koszinowski U H., Jonjic S, Lewis L. Lanier, and Vidal S M.: Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J Exp Med. 206(3):515-23, 2009.

2008

1. Cekinovic D, Golemac M, Pugel EP, Tomac J, Cicin-Sain L, Slavuljica I, Bradford R, Misch S, Winkler TH, Mach M, Britt WJ, Jonjic S: Passive immunization reduces MCMV induced brain pathology in newborn mice. Journal of Virology, 82(24):12172-80; 2008 (IF: 5.308, Q1 in Virology)

2. Lenac T, Arapovic J, Traven L, Krmpotic A, Jonjic S: Murine cytomegalovirus regulation of NKG2D ligands. Medical Microbiology and Immunology, 197(2):159-66; 2008 (IF: 2.222, Q3 in Immunology and Q2 in Microbiology)

3. Bantug G, Cekinovic D, Bradford R, Koontz T, Jonjic S, Britt W J: CD8+ T-lymphocytes control MCMV replication in the central nervous system of newborn animals. Journal of Immunology, 181(3):2111-23; 2008 (IF: 6.000, Q1 in Immunology)

4. Jonjic S, Babic M, Polic B, Krmpotic A: Immune evasion of natural killer cells by viruses. Current Opinion in Immunology, 20(1):30-8; 2008 (IF: 10.455, Q1 in Immunology)

5. Koontz T, Bralic M, Tomac J, Pernjak-Pugel E, Bantug G, Jonjic S, and Britt W J: Altered Development of the Brain after Focal Herpesvirus Infection of the CNS. Journal of Experimental Medicine, 205(2):423-35; 2008 (IF: 15.463, Q1 in Immunology and Q1 in Medicine, Research & Experimental)

2007

1. Mans J, Natarajan K, Balbo A, Schuck P, Eikel D, Hess S, Robinson H, Simic H, Jonjic S, Tiemessen CT, Margulies D H: Cellular Expression and Crystal Structure of the Murine Cytomegalovirus MHC-Iv Glycoprotein, m153. Journal of Biological Chemistry, 282(48):35247-58; 2007 (IF: 5.581, Q1 in Biochemistry and Molecular Biology)

2006

1. Lenac T, Budt M, Arapovic J, Hasan M, Zimmermann A, Simic H, Krmpotic A, Messerle M, Ruzsics Z, Koszinowski U H, Hengel H, Jonjic S: The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J Exp Med. 203(8):1843-50, 2006.